š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
The primary objective of this pilot study to evaluate the safety of low dos...
Status
Completed
Location
Baylor College of Medicine
Start Date
2017-12-08
Trial ID
NCT03063736
Treatments Being Tested
The primary goal of this prospective clinical trial is to evaluate the safe...
Status
Active Not Recruiting
Location
Duke University Medical Center
Start Date
2018-06-29
Trial ID
NCT03299309
Treatments Being Tested
This clinical trial aims to investigate how exposure to Perfluorononanoic a...
Status
Completed
Location
EOHSI Paulsboro Office
Start Date
2024-11-04
Trial ID
NCT06588530
Treatments Being Tested
To compare the seroprotection rates and booster responses to Canadian-manuf...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00601835
This phase II trial compares the effect of folate receptor alpha dendritic ...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-11-08
Trial ID
NCT06639074
Treatments Being Tested
This single-arm phase II study will assess the impact of tetanus pre-condit...
Status
Terminated
Location
Duke University Medical Center
Start Date
2019-09-30
Trial ID
NCT03927222
The purpose of this study is to assess whether immunization against pertuss...
Status
Completed
Location
Clinical Trial Research Center - Canadian Center for Vaccinology
Start Date
2007-11
Trial ID
NCT00553228
The purpose of this study is to describe the safety and immunogenicity of r...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01439165